|Have Questions?||Leave a Message or Start an on-line Chat|
To generate the MYL9 recombinant monoclonal antibody, the MYL9 antibody genes were initially integrated into plasmid vectors. These engineered plasmid vectors were subsequently introduced into suitable host cells utilizing exogenous protein expression techniques to facilitate antibody production. Subsequent to this production phase, the MYL9 recombinant monoclonal antibody underwent purification via affinity chromatography. This antibody is suitable for ELISA. In the functional ELISA, it was established that the MYL9 recombinant monoclonal antibody demonstrated robust binding to the human MYL9 protein (CSB-YP015318HU) at a concentration of 2 μg/mL, displaying an EC50 within the range of 4.628 to 6.430 ng/mL.
MYL9 is a versatile protein that functions as a regulatory subunit of myosin II in both muscle and non-muscle cells. Its main roles include regulating muscle contraction, controlling cell motility, and participating in various cellular processes associated with changes in cell shape and movement. The phosphorylation of MYL9 and its interactions with other proteins are central to its functions in these processes.
There are currently no reviews for this product.